The Patent Finder

Proximagen Neuroscience PLC

Also on record
Records under this name other than patents Proximagen Neuroscience PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Proximagen Neuroscience PLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,465,467Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
Formerly held
Term ended
Term ended May 19, 2020 · USPTO record
Term endedTerm ended May 19, 2020USPTO record
US 8,030,316Malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine
Formerly held
Lapsed on the fee record
Ended Oct 4, 2019 · USPTO record
Lapsed on the fee recordEnded Oct 4, 2019USPTO record
US 7,129,354Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds
Formerly held
Lapsed on the fee record
Ended Oct 31, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 31, 2018USPTO record
US 7,820,677Phosphoric acid addition salt of (2R)-1-[3-(2-{[2-(2-dimethylaminoethoxy)-3-pyridinyl]oxy}-ethoxy)-2-pyrazinyl]-2-methylpiperazine
Formerly held
Lapsed on the fee record
Ended Oct 26, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 26, 2018USPTO record
US 7,812,0174-substituted indole and indoline compounds
Formerly held
Lapsed on the fee record
Ended Oct 12, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 12, 2018USPTO record
US 8,835,439Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseases
Formerly held
Lapsed on the fee record
Ended Sep 16, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 16, 2018USPTO record
US 7,071,180Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Formerly held
Lapsed on the fee record
Ended Jul 4, 2018 · Low confidence
Lapsed on the fee recordEnded Jul 4, 2018Low confidence
US 7,534,794Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Formerly held
Lapsed on the fee record
Ended May 19, 2017 · Medium confidence
Lapsed on the fee recordEnded May 19, 2017Medium confidence
US 8,410,113(2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof
Formerly held
Lapsed on the fee record
Ended Apr 2, 2017 · USPTO record
Lapsed on the fee recordEnded Apr 2, 2017USPTO record
US 6,756,377Compounds and their use
Formerly held
Lapsed on the fee record
Ended Jun 29, 2016 · USPTO record
Lapsed on the fee recordEnded Jun 29, 2016USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited